OBR Daily Commentary

forumImage

PBM Middlemen Continue to Dodge Responsibility for Patient Suffering and Rising Drug Prices

(COA) Apr 9, 2019 - COA applauds the senate finance committee for PBM hearing as part of national efforts to shed light on PBM abuses and lower drug prices. More investigation and oversight needed to examine adverse impact of PBM abuses on patient care.

Read Article arrow

Ted Okon (Posted: April 11, 2019)

quotesPBMs are getting more brazen in how they delay and deny cancer patients their oral drugs. Anyone in practice knows that. The Senate Finance hearing was a necessary first step but a lot more needs to be done — especially focusing on how PBMs are adversely impacting patient care.quotes

Add Comment 1 Comment
forumImage

Fact Checking the NYT Fact Check on the Trump Proposal

(MSK Drug Pricing Lab) Dec 17, 2018 - The Drug Pricing Lab takes issue with The New York Times ‘Fact Check’ on the recent Trump Administration proposal to pilot alternative reimbursement for Part B drugs.

Read Article arrow

Ted Okon (Posted: December 18, 2018)

quotesAs I informed Dr. Bach, at least one of his "fact check" statements are not factual. "...McKesson, which owns Texas Oncology (part of US Oncology)" is not correct because the physicians of Texas Oncology own Texas Oncology. It calls into question what other "fact checks" by Dr. Bach are incorrect.quotes

Add Comment 1 Comment
forumImage

Azar Announces Mandatory Oncology Payment Model Is Coming

(AJMC Managed Markets Network) Nov 8, 2018 - A mandatory payment model is coming in oncology care, HHS Secretary Alex Azar said today during an appearance at a value-based care summit. Azar said that the administration would “revisit” mandatory models that it had previously scrapped in cardiac care and said the time had come for “exploring new and improved episode-based models in other areas, including radiation oncology.” Right now, the Centers for Medicare and Medicaid Innovation is working with practices on care transformation through the Oncology Care Model, or OCM, but that that 5-year pilot is voluntary.

Read Article arrow

Ted Okon (Posted: November 08, 2018)

quotesThis is yet another mandatory experiment on cancer patient care that is terrible medicine and unconstitutional by using the Medicare Innovation Center to bypass the Congress and existing law. The regulators are now running medicine, and that is both scary and dangerous!quotes

Add Comment 1 Comment

Meet the Editorial Board

Prostate Cancer
member photo
Tomasz M. Beer, MD, FACP

Professor of Medicine, Division of Hematology/Medical O...

Community Oncology
member photo
Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology...

Breast Cancer
member photo
Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncol...

Lung Cancer
member photo
H. Jack West, MD

Associate Clinical Professor, Medical Oncology Executi...

Gastrointestinal Cancers
member photo
Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Woo...

Radiation Oncology
member photo
Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics
Pr...

Community Oncology
member photo
Jeff Patton, M.D.

CEO Tennessee Oncology...

Precision Medicine Section Editor
member photo
Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One...

Financial Sector
member photo
Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst...

Gastrointestinal Cancers
member photo
Richard Goldberg, MD

Director WVU Cancer Institute Director of Cancer Signa...

Editor-In-Chief
member photo
Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology...

Health Policy
member photo
Ted Okon

Executive Director Community Oncology Alliance...

Community Oncology
member photo
Thomas Marsland, MD

Vice President Integrated Community Oncology Network ...

Community Oncology
member photo
William Harwin MD

Florida Cancer Specialists President and Managing Part...

Health Policy
member photo
William McGivney, PhD

National Health Policy Expert...

Payer
member photo
Winston Wong, PharmD

President, W-Squared Group...